Jude Medical, Inc.
announced definitive agreement for Abbott to acquire St.
Jude Medical, creating a premier medical device leader with top positions in high-growth cardiovascular markets, including atrial fibrillation, structural heart and heart failure as well as a leading position in the high-growth neuromodulation market. Under the agreement, St.
Jude Medical shareholders will receive $46.75 in cash and 0.8708 shares of Abbott common stock, representing total consideration of approximately $85 per share.
At an Abbott stock price of $43.93(2), this represents a total transaction...(continua)